APA

Pinkerton A. B., Sergienko E., Bravo Y., Dahl R., Ma C., Sun Q., Jackson M. R., Cosford N. D. P. & Millán J. L. (20180112). Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor. : Bioorganic & medicinal chemistry letters.

Chicago

Pinkerton Anthony B, Sergienko Eduard, Bravo Yalda, Dahl Russell, Ma Chen-Ting, Sun Qing, Jackson Michael R, Cosford Nicholas D P and Millán José Luis. 20180112. Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor. : Bioorganic & medicinal chemistry letters.

Harvard

Pinkerton A. B., Sergienko E., Bravo Y., Dahl R., Ma C., Sun Q., Jackson M. R., Cosford N. D. P. and Millán J. L. (20180112). Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor. : Bioorganic & medicinal chemistry letters.

MLA

Pinkerton Anthony B, Sergienko Eduard, Bravo Yalda, Dahl Russell, Ma Chen-Ting, Sun Qing, Jackson Michael R, Cosford Nicholas D P and Millán José Luis. Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor. : Bioorganic & medicinal chemistry letters. 20180112.